CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $446,000 | -19.9% | 4,763 | -24.8% | 0.01% | -33.3% |
| Q2 2015 | $557,000 | -24.5% | 6,335 | -51.9% | 0.01% | -10.0% |
| Q4 2014 | $738,000 | +23.4% | 13,179 | 0.0% | 0.01% | +11.1% |
| Q3 2014 | $598,000 | +9.5% | 13,179 | 0.0% | 0.01% | +12.5% |
| Q2 2014 | $546,000 | -24.5% | 13,179 | +22.1% | 0.01% | -27.3% |
| Q2 2013 | $723,000 | – | 10,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |